We are live on
!
Find out more
LS
Leelyn Smith Portfolio holdings
AUM
$822M
1-Year Est. Return
31.69%
This Fund
S&P 500
This Quarter
Est. Return
+16.11%
1 Year Est. Return
+31.69%
3 Year Est. Return
+77.34%
5 Year Est. Return
+91.98%
10 Year Est. Return
–
AUM
$243M
AUM Growth
+$55.2M
(+29%)
Cap. Flow
+$46.5M
Cap. Flow
% of AUM
19.17%
Top 10 Holdings %
Top 10 Hldgs %
43.97%
Holding
439
New
112
Increased
115
Reduced
72
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$24.2M |
| 2 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$2.84M |
| 3 |
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
|
+$2.46M |
| 4 |
ExxonMobil
XOM
|
+$2.14M |
| 5 |
Vanguard Morningstar Mega Cap Growth ETF
MGK
|
+$1.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$2.22M |
| 2 |
Microsoft
MSFT
|
+$2.06M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.93M |
| 4 |
Blackrock
BLK
|
+$1.33M |
| 5 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$634K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.37% |
| 2 | Consumer Discretionary | 6.6% |
| 3 | Industrials | 5.97% |
| 4 | Consumer Staples | 5.81% |
| 5 | Healthcare | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Janus Henderson Short Duration Income ETF
VNLA
$3.41B
| $20.5M | 8.43% |
406,895
-5,873
| -1% | -$293K |
|
2
iShares MSCI USA Min Vol Factor ETF
USMV
$24.3B
| $18.5M | 7.62% |
304,816
+10,811
| +4% | +$642K |
|
3
VanEck Morningstar Wide Moat ETF
MOAT
$12.4B
| $14.8M | 6.1% |
283,218
+12,668
| +5% | +$631K |
|
|
4
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.1B
| $14.1M | 5.81% |
431,445
+49,575
| +13% | +$1.48M |
|
|
5
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
$291M
| $11.4M | 4.7% |
355,132
+88,149
| +33% | +$2.46M |
|
6
Schwab US Dividend Equity ETF
SCHD
$112B
| $8.37M | 3.45% |
485,022
+30,354
| +7% | +$513K |
|
7
Amazon
AMZN
$2.81T
| $5.85M | 2.41% |
38,660
+6,480
| +20% | +$783K |
|
|
8
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17.4B
| $5.15M | 2.12% |
50,677
+28,150
| +125% | +$2.84M |
|
9
Apple
AAPL
$4.51T
| $4.3M | 1.77% |
47,176
+7,672
| +19% | +$595K |
|
10
Vanguard High Dividend Yield ETF
VYM
$83.1B
| $3.78M | 1.56% |
48,060
+1,101
| +2% | +$85.6K |
|
11
McDonald's
MCD
$191B
| $3.73M | 1.54% |
20,250
+3,776
| +23% | +$692K |
|
12
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.45B
| $3.52M | 1.45% |
106,927
+1,902
| +2% | +$61.9K |
|
13
Lockheed Martin
LMT
$129B
| $3.43M | 1.41% |
9,406
+393
| +4% | +$148K |
|
14
Microchip Technology
MCHP
$39.9B
| $3.19M | 1.32% |
37,872
+28,438
| +301% | +$1.28M |
|
15
First Trust Morningstar Dividend Leaders Index Fund
FDL
$8.11B
| $3.03M | 1.25% |
119,428
+675
| +0.6% | +$16.8K |
|
|
16
3M
MMM
$92.7B
| $2.76M | 1.14% |
211,568
+191,973
| +980% | +$24.2M |
|
17
Applied Materials
AMAT
$382B
| $2.69M | 1.11% |
44,445
+5,236
| +13% | +$282K |
|
18
Visa
V
$713B
| $2.59M | 1.07% |
13,421
+1,561
| +13% | +$285K |
|
19
Berkshire Hathaway Class B
BRK.B
$1.08T
| $2.49M | 1.02% |
13,402
+624
| +5% | +$114K |
|
20
Mastercard
MA
$522B
| $2.17M | 0.89% |
7,329
+643
| +10% | +$181K |
|
|
21
ExxonMobil
XOM
$665B
| $2.16M | 0.89% |
48,396
+47,702
| +6,873% | +$2.14M |
|
22
Invesco QQQ Trust
QQQ
$485B
| $2.16M | 0.89% |
8,717
+1,929
| +28% | +$432K |
|
23
AbbVie
ABBV
$471B
| $2.11M | 0.87% |
21,485
-414
| -2% | -$36.5K |
|
24
UnitedHealth
UNH
$356B
| $2.08M | 0.86% |
7,065
+658
| +10% | +$189K |
|
25
Intel
INTC
$468B
| $2.01M | 0.83% |
33,626
-1,433
| -4% | -$85.7K |
|
Similar funds
SCM
SCP
GSWM
HVIA
MGAM
IA
WRPWM
RP
Leelyn Smith's Q2 2020 Portfolio in Review
As of Q2 2020, Leelyn Smith held 439 positions worth $243M, up 29% from $187M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Leelyn Smith deployed $46.5M of net new capital in Q2 2020, opening 112 new positions and adding to 115 existing holdings. Its largest new stake was First Trust NYSE Arca Biotechnology Index Fund: 1,814 shares worth $304K.
By sector, the portfolio is most concentrated in Technology at 9.4% of assets, up from 8.3% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Clorox, an estimated $2.22M trimmed.
- Leelyn Smith's largest Q2 2020 buy was First Trust NYSE Arca Biotechnology Index Fund: 1,814 shares worth $304K.
- Leelyn Smith added most to 3M in Q2 2020, an estimated $24.2M increase.
- Leelyn Smith's biggest Q2 2020 reduction was Clorox, cutting an estimated $2.22M.
- Leelyn Smith fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, selling an estimated $333K.
- Leelyn Smith's ten largest holdings make up 44% of its $243M portfolio in Q2 2020.
- Leelyn Smith opened 112 new positions and closed 39 in Q2 2020.
- Leelyn Smith's portfolio value rose 29% quarter-over-quarter to $243M.
Based on Leelyn Smith's 13F filing for Q2 2020, filed 6 Aug 2020.